Overview

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Status:
Completed
Trial end date:
2010-01-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SB-649868 is safe, tolerable after repeated administrations in adult and elderly healthy volunteers. Pharmacokinetics and effects on cardiac function of repeated doses are studied
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline